| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 6, 2005
Accepted on July 11, 2005
Laboratory of Neuroendocrinoimmunology, Department of Internal Medicine I, Division of Rheumatology, University Hospital, 93042 Regensburg, Germany; Department of Medicine V, Division of Rheumatology, University of Heidelberg, Hospitalstrasse 3, 69115 Heidelberg, Germany; Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, U.S.A.
* To whom correspondence should be addressed. E-mail: rainer.straub{at}klinik.uni-regensburg.de.
Context: Tumor necrosis factor (TNF)-receptor-associated periodic syndrome (TRAPS) is a hereditary fever syndrome which results from mutations in the TNF-receptor superfamily 1A gene (TNFRSF1A). It is characterized by periodic fever, arthralgia, abdominal pain, myalgia, headache, and skin lesions.
Objective: Since adrenal and gonadal hormone cascades are modulated by TNF, this study aimed to investigate specific hormones and enzyme steps during an attack phase in a women with TRAPS.
Design: Morning blood samples were taken from a 38 yr-old women before, during, and after the febrile episode in the late luteal, menstrual, and early follicular phase of the menstrual cycle, respectively.
Results: Serum cortisol levels were markedly increased throughout the entire observation period and demonstrated a dip during the attack phase. In contrast, serum levels of dehydroepiandrosterone (DHEA) and 17-hydroxyprogesterone demonstrated a sharp rise during the febrile episode. DHEA in relation to androstenedione or cortisol was increased. Indicative of aromatase activation, estrone and 17
-estradiol demonstrated a marked increase during the attack phase.
Conclusion: This study suggests that some important steroid hormone conversion steps are activated (aromatase) and inhibited (second step of the P450c17 and the 3
-hydroxysteroid dehydrogenase) during the inflammatory attack phase in a TRAPS patient. These changes of enzyme pathways are typical on the basis of increased TNF signaling.
-estradiol
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |